Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Whole brain radiotherapy with volumetric-modulated arc therapy for pediatric intracranial embryonic carcinoma prevents permanent alopecia.
Iwai A, Umeda K, Uto M, Nihira H, Kawaguchi K, Mikami M, Nodomi S, Saida S, Hiramatsu H, Ogura K, Tanji M, Arakawa Y, Sakamoto T, Adachi S, Mizowaki T, Heike T. Iwai A, et al. Among authors: kawaguchi k. Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26434. Epub 2017 Jan 2. Pediatr Blood Cancer. 2017. PMID: 28042910 No abstract available.
Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
Kawaguchi K, Umeda K, Hiejima E, Iwai A, Mikami M, Nodomi S, Saida S, Kato I, Hiramatsu H, Yasumi T, Nishikomori R, Kondo T, Takaori-Kondo A, Heike T, Adachi S. Kawaguchi K, et al. Int J Hematol. 2018 Jul;108(1):66-75. doi: 10.1007/s12185-018-2442-2. Epub 2018 Mar 26. Int J Hematol. 2018. PMID: 29582333
CD146 is a potential immunotarget for neuroblastoma.
Obu S, Umeda K, Ueno H, Sonoda M, Tasaka K, Ogata H, Kouzuki K, Nodomi S, Saida S, Kato I, Hiramatsu H, Okamoto T, Ogawa E, Okajima H, Morita K, Kamikubo Y, Kawaguchi K, Watanabe K, Iwafuchi H, Yagyu S, Iehara T, Hosoi H, Nakahata T, Adachi S, Uemoto S, Heike T, Takita J. Obu S, et al. Among authors: kawaguchi k. Cancer Sci. 2021 Nov;112(11):4617-4626. doi: 10.1111/cas.15124. Epub 2021 Sep 30. Cancer Sci. 2021. PMID: 34464480 Free PMC article.
A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20).
Tomizawa D, Tsujimoto SI, Tanaka S, Matsubayashi J, Aoki T, Iwamoto S, Hasegawa D, Nagai K, Nakashima K, Kawaguchi K, Deguchi T, Kiyokawa N, Ohki K, Hiramatsu H, Shiba N, Terui K, Saito AM, Kato M, Taga T, Koshinaga T, Adachi S. Tomizawa D, et al. Among authors: kawaguchi k. Jpn J Clin Oncol. 2022 Oct 6;52(10):1225-1231. doi: 10.1093/jjco/hyac105. Jpn J Clin Oncol. 2022. PMID: 35809896 Clinical Trial.
1,506 results